H.B. Fuller (FUL) Prices $850 Million Notes To Fund A Medical Deal

• H.B. Fuller (NYSE:FUL) has announced an offering of US$850 million in senior unsecured notes to support a pending acquisition.
• The bond issuance is intended to fund H.B. Fuller's purchase of Advanced Medical Solutions Group plc in the medical sector.
• Terms of the senior unsecured notes link the financing directly to the completion of the Advanced Medical Solutions Group plc transaction.
• The US$850 million senior unsecured notes tied to the Advanced Medical Solutions deal only capture one piece of today's story. Check out 6 other big wins that H.B. Fuller investors should know about.

This move into medical end markets is not unique to H.B. Fuller, and other businesses with related exposure appear in 38 profitable AI stocks that aren't just burning cash.

H.B. Fuller operates as a specialty chemicals producer, supplying adhesives, sealants, coatings, and related products to a wide range of industrial end markets. Acquiring Advanced Medical Solutions would extend that expertise further into healthcare applications.

See how H.B. Fuller's balance sheet measures up.

H.B. Fuller takes on higher coupon debt to pursue medical growth

For investors in H.B. Fuller, this US$850 million, 7.625% senior unsecured issue leans into the existing Narrative tension between growth through acquisitions and already elevated leverage. The new notes help fund the Advanced Medical Solutions deal and tidy up the debt stack by targeting repayment of the 4.000% notes due 2027 and other borrowings. At the same time, the major risk flagged in the Narrative, that debt is not well covered by operating cash flow, stays front and center. The partial redemption feature if the AMS transaction falls over limits some financing risk but does not change the fact that gross debt remains a key swing factor for this story.

See how these catalysts shape H.B. Fuller's path to a $69.86 fair value.

The next things to watch are whether the AMS acquisition actually closes by the current target timeline and, once it does, how quickly H.B. Fuller’s reported net debt to EBITDA starts to move toward its long term leverage goals in subsequent quarterly results.

One more thing on H.B. Fuller that could matter just as much

Balance sheet moves tell only part of the story for H.B. Fuller, because who actually runs the business and how their pay is structured can pull decisions in very different directions. See who is actually steering H.B. Fuller, and how they are paid.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com